We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Strawberry Consumption May Provide Protection against Cardiovascular Disease

By Biotechdaily staff writers
Posted on 18 Oct 2007
A recent women's health study demonstrated that strawberries might help decrease the risk of having elevated inflammation in blood vessels.

Strawberries are not only nutrient-rich, new research from Harvard Medical School (Cambridge, MA, USA) found that those who reported eating the most strawberries experienced lower blood levels of C-reactive protein (CRP), a biomarker for inflammation in the blood vessels.

Howard Sesso, Sc.D., and colleagues at the Harvard School of Public Health reported their findings in the August 2007 issue of the Journal of the American College of Nutrition. More...
Using dietary intake records of approximately 27,000 of the women who participated in the decade-long Women's Health Study, Dr. Sesso evaluated the levels of strawberry consumption and several risk factors for cardiovascular disease. The findings revealed that women who ate the most strawberries--two or more servings per week--compared to those who reported eating none in the past month, were 14% less likely to have elevated C-reactive protein levels.

CRP is a blood biomarker that signals the presence of inflammation in the body. Elevated levels of CRP have been shown in a variety of studies to be a potentially good predictor of risk for both heart disease and stroke, as it is typically a sign of atherosclerosis. As a result, The Centers for Disease Control and American Heart Association have established guidelines suggesting that blood levels of CRP higher than 3 mg/l may be important in the risk stratification and prevention of cardiovascular disease.

Researchers found that those women who had higher strawberry intakes were also more likely to lead a heart-healthy lifestyle. On average, women in the highest strawberry intake group ate approximately twice as many servings of fruits and vegetables every day as did women in the lowest intake group. Not surprisingly, they had much higher average intakes of important heart-healthy nutrients such as fiber, vitamin C, potassium, and folate.

These women were also most likely to be non-smokers and get daily physical activity. Moreover, the high strawberry consumers had modestly lower levels of both total and low-density lipoprotein (LDL) cholesterol, the so-called "bad” cholesterol.

"Higher intakes of fruits and vegetables have consistently been associated with a reduced risk of cardiovascular disease [CVD]. Strawberries are a rich source of several key nutrients and phytonutrients that may play a role in protecting heart health. This is the first study to show that strawberries may help reduce the likelihood of having elevated CRP levels in the blood. While more research is needed, this study helps provide more evidence that eating fruits and vegetables will help reduce risk for cardiovascular disease,” said Dr. Sesso.


Related Links:
Harvard Medical School

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.